Shipin Wu
Impact in
-
- Liver physiology and pathology
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Hongtao Chen (1 shared paper)Jinhua He (1 shared paper)Hongtao Chen (3 shared papers)Shang‐Zhong Xu (1 shared paper)Xiaobin Zeng (4 shared papers)Lanlan Ge (4 shared papers)Haoqiang Wan (3 shared papers)Lingyun Xiao (3 shared papers)
In The Last Decade
Shipin Wu
18 papers receiving 283 citations
Peers
Comparison fields: 5 of 75
- Hepatology 43
- Cancer Research 70
- Immunology 64
- Biochemistry 16
- Genetics 23
Countries citing papers authored by Shipin Wu
This map shows the geographic impact of Shipin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipin Wu more than expected).
Fields of papers citing papers by Shipin Wu
This network shows the impact of papers produced by Shipin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipin Wu. The network helps show where Shipin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shipin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 51 | |
| 2 | 2018 | 29 | |
| 3 | 2021 | 28 | |
| 4 | 2020 | 27 | |
| 5 | 2018 | 27 | |
| 6 | 2020 | 26 | |
| 7 | 2020 | 21 | |
| 8 | 2017 | 19 | |
| 9 | 2020 | 16 | |
| 10 | 2020 | 13 | |
| 11 | 2022 | 10 | |
| 12 | 2019 | 8 | |
| 13 | 2020 | 4 | |
| 14 | 2025 | 2 | |
| 15 | 2021 | 2 | |
| 16 | Clinical Efficacy of Dahuang Zhechong Pill on Chronic Hepatitis with Hepatic Fibrosis | 2008 | 2 |
| 17 | 2019 | 2 | |
| 18 | [Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C]. | 2004 | 1 |
About Shipin Wu
Shipin Wu is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Immunology and Hepatology, having authored 18 papers that have together received 288 indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), MicroRNA in disease regulation (2 papers), Liver physiology and pathology (2 papers), Influenza Virus Research Studies (2 papers), Hepatitis B Virus Studies (2 papers), Hepatitis C virus research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Phytochemistry and Biological Activities (2 papers). The work is most often cited by research in Hepatology (43 citations), Cancer Research (70 citations), Immunology (64 citations), Biochemistry (16 citations) and Genetics (23 citations). Shipin Wu has collaborated with scholars based in China, Lebanon and Germany. Frequent co-authors include Hongtao Chen, Jinhua He, Hongtao Chen, Shang‐Zhong Xu, Xiaobin Zeng, Lanlan Ge, Haoqiang Wan, Lingyun Xiao, Xiaoyong Zhang and Boping Zhou. Their work appears in journals such as Frontiers in Immunology, Phytomedicine, International Journal of Biological Macromolecules, New Journal of Chemistry and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.